Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Temporal Bone | 22 | 2023 | 102 | 7.580 |
Why?
|
| Ear Neoplasms | 9 | 2020 | 59 | 3.390 |
Why?
|
| Ear Canal | 7 | 2022 | 31 | 3.030 |
Why?
|
| Skull Base Neoplasms | 10 | 2020 | 314 | 1.750 |
Why?
|
| Skull Neoplasms | 5 | 2016 | 67 | 1.720 |
Why?
|
| Osteoradionecrosis | 5 | 2021 | 123 | 1.700 |
Why?
|
| Neuroma, Acoustic | 3 | 2023 | 55 | 1.500 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2024 | 144 | 1.470 |
Why?
|
| Facial Nerve | 6 | 2022 | 64 | 1.470 |
Why?
|
| Head and Neck Neoplasms | 8 | 2021 | 3976 | 1.420 |
Why?
|
| Neurosurgical Procedures | 6 | 2020 | 609 | 1.360 |
Why?
|
| Otologic Surgical Procedures | 4 | 2018 | 33 | 1.270 |
Why?
|
| Bone Neoplasms | 5 | 2022 | 2576 | 1.010 |
Why?
|
| Cochlear Implants | 1 | 2024 | 40 | 0.920 |
Why?
|
| Cochlear Implantation | 1 | 2024 | 45 | 0.910 |
Why?
|
| Speech Perception | 1 | 2024 | 66 | 0.880 |
Why?
|
| Osteoblastoma | 1 | 2022 | 15 | 0.840 |
Why?
|
| Osteoma, Osteoid | 1 | 2022 | 22 | 0.840 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2022 | 21 | 0.840 |
Why?
|
| Ear, Middle | 4 | 2017 | 48 | 0.820 |
Why?
|
| Facial Nerve Diseases | 3 | 2019 | 21 | 0.810 |
Why?
|
| Osteonecrosis | 1 | 2022 | 53 | 0.800 |
Why?
|
| Skull Base | 5 | 2023 | 199 | 0.770 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 119 | 0.770 |
Why?
|
| Facial Nerve Injuries | 2 | 2018 | 13 | 0.690 |
Why?
|
| Hearing Loss | 4 | 2022 | 153 | 0.690 |
Why?
|
| Mycosis Fungoides | 1 | 2022 | 320 | 0.680 |
Why?
|
| Metformin | 1 | 2023 | 378 | 0.670 |
Why?
|
| Facial Paralysis | 3 | 2022 | 60 | 0.670 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2019 | 49 | 0.660 |
Why?
|
| Radiotherapy, Conformal | 2 | 2021 | 902 | 0.620 |
Why?
|
| Skin Neoplasms | 4 | 2022 | 4654 | 0.620 |
Why?
|
| Electromyography | 1 | 2018 | 226 | 0.620 |
Why?
|
| Retrospective Studies | 29 | 2024 | 37905 | 0.600 |
Why?
|
| Endoscopy | 2 | 2020 | 479 | 0.600 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2017 | 272 | 0.600 |
Why?
|
| Monitoring, Intraoperative | 1 | 2018 | 264 | 0.580 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2023 | 5437 | 0.570 |
Why?
|
| Carcinoma | 3 | 2023 | 2578 | 0.550 |
Why?
|
| Middle Ear Ventilation | 1 | 2015 | 20 | 0.540 |
Why?
|
| Hearing Aids | 1 | 2015 | 14 | 0.540 |
Why?
|
| Osseointegration | 1 | 2015 | 21 | 0.540 |
Why?
|
| Hearing Loss, Conductive | 1 | 2015 | 15 | 0.540 |
Why?
|
| Otitis Media | 1 | 2015 | 65 | 0.530 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 7 | 0.440 |
Why?
|
| Humans | 63 | 2024 | 261506 | 0.440 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2020 | 1415 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 7702 | 0.430 |
Why?
|
| Postoperative Complications | 7 | 2024 | 5542 | 0.430 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 388 | 0.420 |
Why?
|
| Myxoma | 1 | 2012 | 63 | 0.410 |
Why?
|
| Mastoid | 3 | 2021 | 26 | 0.410 |
Why?
|
| Middle Aged | 32 | 2023 | 86204 | 0.400 |
Why?
|
| Chondrosarcoma | 3 | 2018 | 216 | 0.390 |
Why?
|
| Free Tissue Flaps | 2 | 2012 | 372 | 0.380 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 634 | 0.380 |
Why?
|
| Aged | 27 | 2023 | 70117 | 0.380 |
Why?
|
| Radiotherapy | 2 | 2015 | 1824 | 0.370 |
Why?
|
| Parotid Neoplasms | 1 | 2011 | 148 | 0.370 |
Why?
|
| Male | 37 | 2023 | 123000 | 0.370 |
Why?
|
| Female | 38 | 2022 | 141928 | 0.350 |
Why?
|
| Aged, 80 and over | 14 | 2023 | 29902 | 0.340 |
Why?
|
| Combined Modality Therapy | 10 | 2020 | 8865 | 0.330 |
Why?
|
| Prognosis | 10 | 2022 | 21713 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 11 | 2021 | 10035 | 0.330 |
Why?
|
| Adult | 26 | 2023 | 77950 | 0.330 |
Why?
|
| Endolymphatic Sac | 2 | 2023 | 11 | 0.330 |
Why?
|
| Ear | 2 | 2020 | 38 | 0.280 |
Why?
|
| Melanoma | 2 | 2020 | 5317 | 0.270 |
Why?
|
| Temporomandibular Joint | 2 | 2022 | 24 | 0.260 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2016 | 2104 | 0.260 |
Why?
|
| Treatment Outcome | 16 | 2023 | 32848 | 0.260 |
Why?
|
| Tinnitus | 2 | 2022 | 38 | 0.230 |
Why?
|
| Endolymphatic Hydrops | 1 | 2023 | 1 | 0.230 |
Why?
|
| Meniere Disease | 1 | 2023 | 3 | 0.230 |
Why?
|
| Incidence | 4 | 2021 | 5673 | 0.230 |
Why?
|
| Risk Assessment | 3 | 2021 | 6869 | 0.210 |
Why?
|
| Perforator Flap | 1 | 2022 | 93 | 0.200 |
Why?
|
| Pentoxifylline | 1 | 2020 | 35 | 0.190 |
Why?
|
| Giant Cell Tumor of Tendon Sheath | 1 | 2020 | 3 | 0.190 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2020 | 15 | 0.180 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2020 | 15 | 0.180 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2018 | 716 | 0.180 |
Why?
|
| Surgical Equipment | 1 | 2019 | 17 | 0.180 |
Why?
|
| Young Adult | 8 | 2021 | 21445 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 14889 | 0.170 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2014 | 32 | 0.170 |
Why?
|
| Mouth | 1 | 2020 | 122 | 0.170 |
Why?
|
| Immunotherapy | 3 | 2021 | 3341 | 0.170 |
Why?
|
| Cost Control | 1 | 2018 | 48 | 0.170 |
Why?
|
| Diffusion of Innovation | 1 | 2019 | 160 | 0.160 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 78 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 403 | 0.160 |
Why?
|
| Eye | 1 | 2020 | 301 | 0.160 |
Why?
|
| Trigeminal Neuralgia | 1 | 2018 | 42 | 0.160 |
Why?
|
| Surgical Oncology | 1 | 2020 | 190 | 0.150 |
Why?
|
| Patient Safety | 2 | 2020 | 649 | 0.150 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2016 | 726 | 0.150 |
Why?
|
| Needs Assessment | 1 | 2018 | 233 | 0.150 |
Why?
|
| Skin | 1 | 2022 | 1259 | 0.140 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 755 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2022 | 4744 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2020 | 7551 | 0.140 |
Why?
|
| United States | 5 | 2020 | 15433 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 2232 | 0.140 |
Why?
|
| Radiation Injuries | 2 | 2016 | 1411 | 0.140 |
Why?
|
| Disease-Free Survival | 5 | 2017 | 10001 | 0.140 |
Why?
|
| Radiotherapy, Adjuvant | 4 | 2020 | 2231 | 0.140 |
Why?
|
| Chordoma | 1 | 2017 | 163 | 0.140 |
Why?
|
| Paraganglioma | 1 | 2018 | 170 | 0.140 |
Why?
|
| Hearing | 2 | 2012 | 64 | 0.130 |
Why?
|
| Physician's Role | 1 | 2018 | 238 | 0.130 |
Why?
|
| Microsurgery | 3 | 2016 | 244 | 0.130 |
Why?
|
| Pheochromocytoma | 1 | 2018 | 281 | 0.130 |
Why?
|
| Thiosulfates | 1 | 2014 | 8 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 1162 | 0.130 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 13658 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2020 | 3981 | 0.120 |
Why?
|
| Cranial Nerve Diseases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2015 | 110 | 0.120 |
Why?
|
| Bone Diseases | 1 | 2014 | 143 | 0.110 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2022 | 1105 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2018 | 489 | 0.110 |
Why?
|
| Craniospinal Irradiation | 1 | 2014 | 128 | 0.110 |
Why?
|
| Parotid Gland | 1 | 2013 | 112 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 2488 | 0.110 |
Why?
|
| Survival | 1 | 2013 | 177 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 4971 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 851 | 0.110 |
Why?
|
| Carcinoma, Small Cell | 1 | 2015 | 408 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2017 | 795 | 0.110 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2015 | 285 | 0.100 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.100 |
Why?
|
| Survival Rate | 3 | 2017 | 12221 | 0.100 |
Why?
|
| Age Factors | 1 | 2021 | 5377 | 0.100 |
Why?
|
| Risk Factors | 2 | 2021 | 17523 | 0.100 |
Why?
|
| Neck Dissection | 1 | 2013 | 290 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 507 | 0.100 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 4849 | 0.100 |
Why?
|
| Adolescent | 6 | 2015 | 31252 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2023 | 9180 | 0.100 |
Why?
|
| Communication | 1 | 2018 | 876 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 622 | 0.100 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 1249 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 3842 | 0.090 |
Why?
|
| Otolaryngology | 1 | 2012 | 129 | 0.090 |
Why?
|
| Neoplasms | 3 | 2021 | 15193 | 0.090 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2014 | 502 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2403 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2018 | 1589 | 0.090 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 371 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2020 | 3890 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2018 | 1330 | 0.080 |
Why?
|
| Biopsy | 2 | 2017 | 3443 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2010 | 319 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 821 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 7789 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1323 | 0.080 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2017 | 49 | 0.070 |
Why?
|
| Cisplatin | 1 | 2014 | 2432 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2010 | 703 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 1866 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 14289 | 0.070 |
Why?
|
| Ipilimumab | 2 | 2021 | 710 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2011 | 540 | 0.070 |
Why?
|
| Leukemia | 1 | 2014 | 1635 | 0.070 |
Why?
|
| Length of Stay | 1 | 2012 | 1900 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2012 | 2218 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 10331 | 0.060 |
Why?
|
| Surgical Flaps | 1 | 2011 | 927 | 0.060 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2008 | 421 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2020 | 6207 | 0.060 |
Why?
|
| Endolymphatic Duct | 1 | 2023 | 1 | 0.060 |
Why?
|
| Mucoproteins | 1 | 2022 | 25 | 0.060 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2022 | 30 | 0.060 |
Why?
|
| Head | 1 | 2023 | 249 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2023 | 665 | 0.050 |
Why?
|
| Tocopherols | 1 | 2020 | 19 | 0.050 |
Why?
|
| Arteries | 1 | 2022 | 274 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 4844 | 0.050 |
Why?
|
| Child | 5 | 2014 | 29154 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2023 | 243 | 0.050 |
Why?
|
| Occupational Health | 1 | 2020 | 95 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2022 | 577 | 0.040 |
Why?
|
| Pharyngeal Diseases | 1 | 1999 | 53 | 0.040 |
Why?
|
| Cutaneous Fistula | 1 | 1999 | 46 | 0.040 |
Why?
|
| Breakthrough Pain | 1 | 2018 | 17 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 2307 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 4320 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2020 | 285 | 0.040 |
Why?
|
| Fistula | 1 | 1999 | 76 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 252 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 175 | 0.040 |
Why?
|
| Neck Pain | 1 | 2018 | 39 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 1038 | 0.040 |
Why?
|
| Laryngectomy | 1 | 1999 | 242 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2020 | 702 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 1013 | 0.040 |
Why?
|
| Petrous Bone | 1 | 2016 | 9 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 1391 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 699 | 0.040 |
Why?
|
| Survivors | 1 | 2022 | 1031 | 0.040 |
Why?
|
| Steroids | 1 | 2018 | 356 | 0.030 |
Why?
|
| Craniotomy | 1 | 2018 | 304 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 2018 | 315 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 978 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1999 | 749 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2018 | 380 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2020 | 884 | 0.030 |
Why?
|
| Disease Progression | 2 | 2018 | 6682 | 0.030 |
Why?
|
| Auditory Threshold | 1 | 2014 | 26 | 0.030 |
Why?
|
| Animals | 1 | 2020 | 59536 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2018 | 403 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 191 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 499 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 2803 | 0.030 |
Why?
|
| Neutropenia | 1 | 1999 | 968 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 953 | 0.030 |
Why?
|
| Wound Healing | 1 | 1999 | 815 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2018 | 1014 | 0.030 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 103 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2023 | 12873 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 2170 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 2055 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2864 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 6009 | 0.030 |
Why?
|
| Otitis Media with Effusion | 1 | 2011 | 20 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 105 | 0.020 |
Why?
|
| Vertigo | 1 | 2010 | 47 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2011 | 119 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 1209 | 0.020 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2010 | 115 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 510 | 0.020 |
Why?
|
| Synkinesis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Facial Asymmetry | 1 | 2009 | 22 | 0.020 |
Why?
|
| Smiling | 1 | 2009 | 16 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 1371 | 0.020 |
Why?
|
| Protons | 1 | 2011 | 473 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 4532 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 4975 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2016 | 2054 | 0.020 |
Why?
|
| Organs at Risk | 1 | 2011 | 514 | 0.020 |
Why?
|
| Graft Survival | 1 | 2011 | 1062 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1360 | 0.020 |
Why?
|
| Video Recording | 1 | 2009 | 267 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 671 | 0.020 |
Why?
|
| Palliative Care | 1 | 2018 | 2037 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.020 |
Why?
|
| Radiometry | 1 | 2011 | 980 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 9244 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1987 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2015 | 4078 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 6295 | 0.010 |
Why?
|
| Pediatrics | 1 | 2011 | 1141 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 3890 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 15862 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 16273 | 0.010 |
Why?
|